Recombinant plasminogen activator therapy for cerebral vein thrombosis in a child carrier of prothrombin gene mutation

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 9, 2002, Pages 769-771

  Tarani, Luigi ^a   Iacobini, Metello ^a   De Stefano, Valerio ^b   Smacchia, Maria Paola ^a   Tozzi, Maria Cristina ^a   Raguso, Grazia ^a   Bruni, Lida ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cerebral vein; Prothrombin gene mutation; Recombinant tissue plasminogen activator; Thrombosis

Indexed keywords

PROTHROMBIN; RECOMBINANT PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG EFFICACY; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; VEIN THROMBOSIS;

BRAIN; CEREBRAL VEINS; CHILD, PRESCHOOL; HETEROZYGOTE DETECTION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PLASMINOGEN ACTIVATORS; PROTHROMBIN; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 0036898608     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200212000-00019     Document Type: Article

References (14)

1. Levy M, Benson L, Burrows PE, et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991;118:467-72.
2. Andrew M, Michelson AD, Bovill E, et al. Guidelines for antithrombotic therapy in pediatric patients. J Pediatr 1998;132:575-88.
3. Farnoux C, Camard O, Pinquier D, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 1998;133:137-40.
4. Weiner GM, Kastle VP, Di Petro MA, et al. Successful treatment of neonatal arterial thrombosis with recombinant tissue plasminogen activator. J Pediatr 1998;133:133-6.
5. Poort SR, Bertina RM, Vos HL. Rapid detection of the prothrombin 20210A variation by allele-specific PCR. Thromb Haemost 1997;78:1157-8.
6. Tsubata S, Ichida F, Hamamichi Y, et al. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease. Pediatr Cardiol 1995:16:186-9.
7. Rosenbaum T, Rammos S, Kniemeyer HW, et al. Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: Successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms. Eur J Pediatr 1993;152:978-80.
8. Nowak-Gottl U, Schwabe D, Schneider W, et al. Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet 1992;340:1105.
9. Ries M, Singer H, Hofbeck M, et al. Tissue plasminogen activator (altepase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J 1994;72:403.
10. Glueck CJ, Crawford A, Roys D, et al. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg Perthes disease. J Bone Joint Surg Am 1996;78:3-13.
11. Hashikura Y, Kawasaki S, Okumura N, et al. Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation 1995;60:1109-12.
12. Bearman SI, Lee LJ, Baron AE, et al. Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 1997;5:1501-6.
13. Wang M, Hays T, Nuss R, et al. Dose finding for tissue plasminogen activator (TPA) thrombolysis in children. Pediatr Res 2001;49:207/A,n.1172
14. Martinelli T, Cacchi E, Landi G, et al. High risk of cerebral vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-7.